|
Human and Animal Cells
|
K562(RCB0027)
|
68494
|
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines.
|
Leukemia |
2000-8-1 |
Pubmed
Full text
|
